Transcriptomics Analysis Reveals Shared Pathways in Peripheral Blood Mononuclear Cells and Brain Tissues of Patients With Schizophrenia

Abstract

Background: Schizophrenia is a serious mental disorder with complicated biological mechanisms. Few studies explore the transcriptional features that are shared in brain tissue and peripheral blood. In the present study, we aimed to explore the biological pathways with similar expression patterns in both peripheral blood mononuclear cells (PBMCs) and brain tissues.Methods: The present study used transcriptomics technology to detect mRNA expression of PBMCs of 10 drug-naïve patients with schizophrenia and 20 healthy controls. Transcriptome data sets of brain tissue of patients with schizophrenia downloaded from public databases were also analyzed in our study. The biological pathways with similar expression patterns in the PBMCs and brain tissues were uncovered by differential expression analysis, weighted gene co-expression network analysis (WGCNA), and pathway analysis. Finally, the expression levels of differential expressed genes (DEGs) were validated by real-time fluorescence quantitative polymerase chain reaction (qPCR) in another 12 drug-naïve patients with schizophrenia and 12 healthy controls.Results: We identified 542 DEGs, 51 DEGs, 732 DEGs, and 104 DEGs in PBMCs, dorsolateral prefrontal cortex, anterior cingulate gyrus, and nucleus accumbent, respectively. Five DEG clusters were recognized as having similar gene expression patterns in PBMCs and brain tissues by WGCNA. The pathway analysis illustrates that these DEG clusters are mainly enriched in several biological pathways that are related to phospholipid metabolism, ribosome signal transduction, and mitochondrial oxidative phosphorylation. The differential significance of PLAAT3, PLAAT4, PLD2, RPS29, RPL30, COX7C, COX7A2, NDUFAF2, and ATP5ME were confirmed by qPCR.Conclusions: This study finds that the pathways associated with phospholipid metabolism, ribosome signal transduction, and energy metabolism have similar expression patterns in PBMCs and brain tissues of patients with schizophrenia. Our results supply a novel insight for revealing the pathogenesis of schizophrenia and might offer a new approach to explore potential biological markers of peripheral blood in schizophrenia.

Blood T Helper Memory Cells: A Tool for Studying Skin Inflammation in HS?

“…Interestingly, a down-regulation of the expression of several ATP-synthase-encoding genes and numerous proteasome subunit genes was recently demonstrated in the brain of patients with schizophrenia [55,56]. More importantly, Song et al found that the transcripts associated with mitochondrial oxidative phosphorylation have similar expression patterns in blood immune cells and brain tissues in patients with schizophrenia [57]. It should be mentioned that despite distinct clinical symptoms, the accumulation of misfolded or aggregated proteins in the brain is characteristic of many neurodegenerative disorders, such as amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, or Alzheimer's disease.…”

Upregulation of S100A8 in peripheral blood mononuclear cells from patients with depression treated with SSRIs: a pilot study

“…According to this integrative approach, both biochemical factors (e.g., hormones, neurotransmitters, growth factors, pro- and anti-inflammatory cytokines) and environmental, genetic, and psychosocial factors may contribute and play a role in the pathophysiology of depression. Examining depression patients through immune system cells provides a novel and distinct perspective compared to the traditional serum or plasma approach; moreover, several authors have proposed PBMC as a useful tool for searching biomarkers of neuropsychiatric disorders [ 8 , 67 – 69 ].…”

“…Proteomic analyses with mononuclear cells, plasma, or serum obtained from peripheral blood samples have increasingly impacted clinical research [ 4 – 7 ]. Notably, peripheral blood mononuclear cells (PBMCs) have great diagnostic power because of the high correlation observed at the transcriptomic level between these cells and the brain [ 8 ]. The identification of potential biomarkers of depression in PBMCs may help to improve the diagnosis of depression, stratify patients and personalize treatment.…”

Unraveling the Pathogenesis of Idiopathic Pulmonary Fibrosis Complicated with Type 2 Diabetes through Microarray Data Analysis

“…In addition, RPL30 has also been identified as a potential biomarker or therapeutic target for depression [48] and schizophrenia [49]. A recent study has shown that the hepatocarcinogenesis through NAFLD&NASH was induced through DNA methylation of RPL30 [50].…”